Gangolli Julian S — SEC insider filings

SEC reporting owner CIK 1532023. 24 insider filings on record with FilingPulse; latest filed 2026-09-16.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2020-08-07 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Krystal Biotech, Inc. (KRYS)Director8—3 legs · 20,000 sh · $3,282,69010
Outlook Therapeutics, Inc. (OTLK)Director10——11
Revance Therapeutics, Inc. (RVNC)Director6——11

Insider filings — Gangolli Julian S

FiledFormIssuerReported transactionsSource
2026-09-164Krystal Biotech, Inc. (KRYS)Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0EDGAR
2025-10-034Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 286,734 (derivative) @ $0EDGAR
2025-06-304Krystal Biotech, Inc. (KRYS)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2025-02-064Revance Therapeutics, Inc. (RVNC)Code (U): 30,106 @ $3.65 · Disposition to issuer (D): 15,000EDGAR
2024-10-034Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 56,636 (derivative) @ $0 · Grant/award (A): 71,169 (derivative) @ $0EDGAR
2024-07-014Krystal Biotech, Inc. (KRYS)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2024-05-224Krystal Biotech, Inc. (KRYS)Option exercise (M): 20,000 @ $22.75 · Sale (S): 10,930 @ $163.71 · Sale (S): 7,090 @ $164.34 · Sale (S): 1,980 @ $165.76 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2024-05-034Revance Therapeutics, Inc. (RVNC)Grant/award (A): 15,000 @ $0 · Grant/award (A): 23,458 (derivative) @ $0EDGAR
2024-03-084Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 94,441 (derivative) @ $0EDGAR
2023-10-064Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 370,282 (derivative) @ $0EDGAR
2023-07-034Krystal Biotech, Inc. (KRYS)Grant/award (A): 6,800 (derivative) @ $0EDGAR
2023-05-054Revance Therapeutics, Inc. (RVNC)Grant/award (A): 3,534 @ $0 · Grant/award (A): 5,915 (derivative) @ $0EDGAR
2023-03-314Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 41,065 (derivative) @ $0EDGAR
2022-10-074Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 74,398 (derivative) @ $0EDGAR
2022-07-014Krystal Biotech, Inc. (KRYS)Grant/award (A): 6,800 (derivative) @ $0EDGAR
2022-05-134/ARevance Therapeutics, Inc. (RVNC)Grant/award (A): 10,756 (derivative) @ $0EDGAR
2022-05-064Revance Therapeutics, Inc. (RVNC)Grant/award (A): 6,059 @ $0 · Grant/award (A): 11,343 (derivative) @ $0EDGAR
2022-03-244Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 21,878 (derivative) @ $0EDGAR
2021-10-074Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 44,466 (derivative) @ $0EDGAR
2021-07-024Krystal Biotech, Inc. (KRYS)Grant/award (A): 6,800 (derivative) @ $0EDGAR
2021-05-074Revance Therapeutics, Inc. (RVNC)Grant/award (A): 4,013 @ $0 · Grant/award (A): 7,551 (derivative) @ $0EDGAR
2021-03-264Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 20,873 (derivative) @ $0EDGAR
2020-10-054Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 150,748 (derivative) @ $0.51EDGAR
2020-08-074Krystal Biotech, Inc. (KRYS)Grant/award (A): 6,800 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1532023 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs